Skip to main content

Lantern Pharma Inc.

LTRN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001763950

No open-market purchases or sales by Lantern Pharma Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $12.0M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Lantern Pharma Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Lantern Pharma Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Lantern Pharma Inc.
NameTitleLast reported holdingLast filingFilings, past year
Keyser D JeffreyDirector94,303May 14, 20262
Schalop Lee TroyDirector48,544May 14, 20262
Maccecchini Maria-LuisaDirector–Jan 13, 20261
Silberstein David S.Director–Jan 13, 20261
Chandru VijayDirector–Jan 13, 20261
Bhatia Kishor G.Chief Scientific Officer–Dec 22, 20251
Margrave David R.Chief Financial Officer–Dec 22, 20251
Sharma PannaPresident & CEO–Sep 23, 20250
BIOS Fund I, LP10% Owner114,272IndirectJun 13, 20250
BIOS Fund I QP, LP10% Owner114,272IndirectJun 13, 20250
BIOS Fund II, LP10% Owner114,272IndirectJun 13, 20250
BIOS Fund II QP, LP10% Owner114,272IndirectJun 13, 20250
BIOS Fund II NT, LP10% Owner114,272IndirectJun 13, 20250
Fletcher Aaron G.L.10% Owner114,272IndirectJun 13, 20250
Bios Equity Partners II, LP10% Owner114,272IndirectJun 13, 20250
Bios Equity Partners, LP10% Owner114,272IndirectJun 13, 20250
BIOS Advisors GP, LLC10% Owner114,272IndirectJun 13, 20250
BIOS Capital Management, LP10% Owner114,272IndirectJun 13, 20250
Cavu Management, LP10% Owner114,272IndirectJun 13, 20250
Cavu Advisors, LLC10% Owner114,272IndirectJun 13, 20250
BP Directors, LP10% Owner114,272IndirectJun 13, 20250
Kreis Leslie W.10% Owner114,272IndirectJun 13, 20250
Prendergast Franklyn GDirector–Nov 8, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 14, 2026 (view filing)May 122 daysSchalop Lee TroyDirectorPPurchaseCommon stock, $0.001 par value+48.5K$2.06+$100.0KNew position48.5K after
May 14, 2026 (view filing)May 122 daysSchalop Lee TroyDirectorPPurchase−48.5K$0.00$0–48.5K afterDerivative
May 14, 2026 (view filing)May 122 daysKeyser D JeffreyDirectorPPurchaseCommon stock, $0.001 par value+48.5K$2.06+$100.0K+106.1%94.3K after
May 14, 2026 (view filing)May 122 daysKeyser D JeffreyDirectorPPurchase−48.5K$0.00$0–48.5K afterDerivative
Jun 13, 2025 (view filing)7:57 PM ETJun 13Same dayBIOS Fund I, LP and 9 others10% OwnerSSale−40.0K$3.09−$123.6K−25.9%114.3K after5 lotsDuplicate filing
Jun 13, 2025 (view filing)7:50 PM ETJun 13Same dayCavu Management, LP and 3 others10% OwnerSSale−40.0K$3.09−$123.6K−25.9%114.3K after5 lots
Jun 13, 2025 (view filing)6:06 AM ETJun 10-123 daysLateBIOS Fund I, LP and 9 others10% OwnerSSale−61.6K$3.38−$208.3K−34.2%118.6K after15 lotsDuplicate filing
Jun 13, 2025 (view filing)6:01 AM ETJun 10-123 daysLateCavu Management, LP and 3 others10% OwnerSSale−61.6K$3.38−$208.3K−34.2%118.6K after15 lots
May 29, 2025 (view filing)9:55 PM ETMay 27-292 daysBIOS Fund I, LP and 9 others10% OwnerSSale−56.2K$2.99−$168.4K−31.0%125.3K after15 lotsDuplicate filing
May 29, 2025 (view filing)9:53 PM ETMay 27-292 daysCavu Management, LP and 3 others10% OwnerSSale−56.2K$2.99−$168.4K−31.0%125.3K after15 lots
May 28, 2024 (view filing)4:31 PM ETMay 23-245 daysCavu Management, LP and 3 others10% OwnerSSale−30.0K$6.30−$189.1K−18.6%131.5K after6 lotsDuplicate filing
May 28, 2024 (view filing)4:30 PM ETMay 23-245 daysBIOS Fund I, LP and 9 others10% OwnerSSale−30.0K$6.30−$189.1K−18.6%131.5K after6 lots
Feb 29, 2024 (view filing)9:54 PM ETFeb 27-292 daysBIOS Fund I, LP and 9 others10% OwnerSSale−144.0K$4.70−$676.3K−51.1%137.8K after9 lotsDuplicate filing
Feb 29, 2024 (view filing)9:54 PM ETFeb 27-292 daysCavu Management, LP and 3 others10% OwnerSSale−144.0K$4.70−$676.3K−51.1%137.8K after9 lots
Jan 19, 2024 (view filing)4:31 PM ETJan 172 daysBIOS Fund I, LP and 9 others10% OwnerSSale−58.9K$4.20−$247.3K−25.9%168.4K after3 lotsDuplicate filing
Jan 19, 2024 (view filing)4:30 PM ETJan 172 daysCavu Management, LP and 3 others10% OwnerSSale−58.9K$4.20−$247.3K−25.9%168.4K after3 lots
Dec 1, 2023 (view filing)6:01 AM ETNov 292 daysBIOS Fund I, LP and 9 others10% OwnerSSale−145.3K$3.44−$500.0K−28.1%371.9K after2 lotsDuplicate filing
Dec 1, 2023 (view filing)6:00 AM ETNov 292 daysCavu Management, LP and 3 others10% OwnerSSale−145.3K$3.44−$500.0K−28.1%371.9K after2 lots
Nov 9, 2022 (view filing)9:39 PM ETNov 81 dayCavu Management, LP and 3 others10% OwnerSSale−350.0K$4.40−$1.54M−68.1%164.1K after5 lotsDuplicate filing
Nov 9, 2022 (view filing)9:37 PM ETNov 81 dayBIOS Fund I, LP and 9 others10% OwnerSSale−350.0K$4.40−$1.54M−68.1%164.1K after5 lots
Sep 7, 2022 (view filing)4:55 PM ETSep 25 daysBIOS Fund I, LP and 9 others10% OwnerSSale−6.45K$5.20−$33.5K−19.8%26.1K after2 lotsDuplicate filing
Sep 7, 2022 (view filing)4:54 PM ETSep 25 daysCavu Management, LP and 3 others10% OwnerSSale−6.45K$5.20−$33.5K−19.8%26.1K after2 lots